Synonym:
7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate,
MK-0431,
Sitagliptin phosphate monohydrate
Properties:
Related Categories |
Analytical Standards,
Analytical/Chromatography,
Pharmacopeia & Metrological Institutes Standards,
USP Standards,
USP Standards S - T
|
Description:
General description
An anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release, stimulates insulin release and lowers blood glucose.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
USP issued SDS can be found here.
Safety:
RIDADR
NONH for all modes of transport